• Understanding of the full clinical potential of Tat inhibitors in in vivo models of HIV latency
• Mechanisms of Tat-independent HIV replication: implications on HIV reservoir formation
• Development of HIV latency promoting agents and their exploration for a functional cure
• Identification and characterization of chromatin regulators and host cellular factors regulating HIV latency and reactivation

Commensurate with experience.

Ph.D. (or MD/PhD) in biological sciences such as virology, molecular biology, cell biology, biochemistry or immunology, with several international publications.

Preference will be given to candidates with:

• Expertise in virology such as cell culture, virus production, lentivirus vector production, p24 ELISA, flow cytometry, etc.
• Work in the BSL3 facility
• Expertise in biochemistry, IP, WB, protein expression and purification 8/31/2022
• Epigenetics ChIP-Seq, ATAC-Seq, etc.
• Small molecule screening
• Work with primary cell models of HIV latency
• Excellent oral communication and written skills in English, with good organizational and analytical abilities.

Preference to candidates with experience with HIV.

Postdoctoral candidates should send an inquiry with cover letter and CV to svalente@ufl.edu

The final candidate will be required to provide official transcript to the hiring department upon hire. A transcript will not be considered "official" if a designation of "Issued to Student" is visible. Degrees earned from an education institution outside of the United States are required to be evaluated by a professional credentialing service provider approved by National Association of Credential Evaluation Services (NACES), which can be found at http://www.naces.org/

This position is open until filled. Application review will begin April 21, 2023.